Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$33.11 - $55.01 $141,909 - $235,772
-4,286 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$50.07 - $66.05 $5,908 - $7,793
118 Added 2.83%
4,286 $215,000
Q2 2021

Aug 10, 2021

SELL
$56.61 - $80.46 $5,661 - $8,045
-100 Reduced 2.34%
4,168 $263,000
Q4 2020

Feb 08, 2021

SELL
$79.17 - $111.47 $7,917 - $11,147
-100 Reduced 2.29%
4,268 $382,000
Q3 2020

Nov 04, 2020

BUY
$81.91 - $134.94 $357,782 - $589,417
4,368 New
4,368 $451,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $420M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Securian Asset Management, Inc Portfolio

Follow Securian Asset Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.